The federal government operates three gigantic systems providing health care to millions of Americans. The VA takes care of veterans, Medicaid (whose costs are shared with states and localities) is coverage for the poor and Medicare is health insurance for seniors and people with disabilities.
The VA and Medicaid can, and do, negotiate with suppliers on drug prices, just like they negotiate payment levels for other health services. Yet Medicare, which sets the reimbursement rates for doctors and hospitals, is barred by federal law from negotiating on drugs.
The prohibition from allowing Medicare to negotiate on drug prices was part of the original legislation when Medicare’s Part D drug benefit was first approved by a Republican Congress and President George W. Bush in 2003. Sen. John McCain, always a truth-teller, said the ban on negotiations was “outrageous,” as Democrats pledged to change it.
It took a long time, but the change finally came last year with President Joe Biden’s hodgepodge Inflation Reduction Act. The law, signed a year ago this month, permitted Uncle Sam (meaning Secretary of Health and Human Services Xavier Becerra ) to haggle over the prices of medications, albeit only a small group of drugs at a time.
Biden has now announced the first 10 drugs. The negotiations, by the Centers for Medicare & Medicaid Services, will take years and the lower prices for consumers will begin in 2026. There will be another 50 drugs over the next four years up for negotiations and after that, 20 a year. And Big Pharma is fighting all the way, already in court to stop it.
